Publication: 2281

Publication: 2281

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer

URL

URL

Google Scholar

Citation:: J Clin Oncol vol 33 (suppl) abstr 9501

Meeting Instance:: ASCO 2015
Year:: 2015
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2452

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:

Pharmas:
Grants:: U10CA037447, U10CA180821, U10CA180882

Corr. Author:
Authors:: Andrew L. Himelstein Rui Qin Paul J. Novotny Drew K. Seisler James L. Khatcheressian John D. Roberts Stephen S. Grubbs Tracey O'Connor Douglas Weckstein Charles L. Loprinzi Charles L. Shapiro

Networks:: CHRISTIANA, FL065, LAPS-MN026, NH038, NY021, VCU

Study: CALGB-70604
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: